Search Results - "Laughlin, Brady S."

Incremental retraining, clinical implementation, and acceptance rate of deep learning auto‐segmentation for male pelvis in a multiuser environment by Duan, Jingwei, Vargas, Carlos E., Yu, Nathan Y., Laughlin, Brady S., Toesca, Diego Santos, Keole, Sameer, Rwigema, Jean Claude M., Wong, William W., Schild, Steven E., Feng, Xue, Chen, Quan, Rong, Yi

“…Background Deep learning auto‐segmentation (DLAS) models have been adopted in the clinic; however, they suffer from performance deterioration owing to the…”
Get full text

Teaming beyond the clinical environment – building collective commitment across graduate medical education by Laughlin, Brady S, Griffeth, Elaine M, Bush, Aaron F, Albold, Cheryll A, Boes, Christopher J, Sadosty, Annie T

“…Abstract This commentary provides evidence and expert opinion on effective relationships and communication strategies for trainee and graduate medical…”
Get full text

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost by Laughlin, Brady S, Silva, Alvin C, Vora, Sujay A, Keole, Sameer R, Wong, William W, Schild, Michael H, Schild, Steven E

“…This retrospective study demonstrates the long-term outcomes of treating prostate cancer using intensity modulated (IMRT) with incorporation of MRI-directed…”
Get full text

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience by Laughlin, Brady S., Bhangoo, Ronik S., Thorpe, Cameron S., Golafshar, Michael A., DeWees, Todd A., Anderson, Justin D., Vern-Gross, Tamara Z., McGee, Lisa A., Wong, William W., Halyard, Michele Y., Keole, Sameer R., Vargas, Carlos E.

“…Background We present Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for patients undergoing adjuvant…”
Get full text

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone by Laughlin, Brady S, Bhangoo, Ronik S, Niska, Joshua R, Thorpe, Cameron S, Girardo, Marlene E, Anderson, Justin D, Kosiorek, Heidi E, McGee, Lisa A, Hartsell, William F, Chang, John H, Rossi, Carl J, Tsai, Henry K, Choi, Isabelle J, Vargas, Carlos E

“…To assess adverse events (AEs) and disease-specific outcomes after proton therapy for isolated local-regional recurrence (LRR) of breast cancer after…”
Get full text

Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma: A Comparative Analysis of Regimens by Laughlin, Brady S., Van Der Walt, Charles, Mangold, Aaron R., Breen, William G., Rosenthal, Allison C., Lester, Scott, Hoppe, Bradford, Peterson, Jennifer, Bogan, Aaron, Rule, William G.

“…Low-dose total skin electron beam therapy (TSEBT) is a proven treatment for managing cutaneous T-cell lymphoma (CTCL) and Sezary syndrome with skin burden. We…”
Get full text

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience by Laughlin, Brady S., Narang, Gopi L., Cheney, Scott M., Humphreys, Mitchell R., Vargas, Carlos E., Keole, Sameer R., Rwigema, Jean‐Claude M., Schild, Steven E., Wong, William W.

“…Purpose/Objectives Holmium laser enucleation of the prostate (HoLEP) is commonly performed in patients with significant bladder outlet obstruction. However,…”
Get full text

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy by Laughlin, Brady S., Voss, Molly M., Toesca, Diego A.S., Daniels, Thomas, Golafshar, Michael A., Keole, Sameer R., Wong, William W., Rwigema, Jean-Claude, Davis, Brian, Schild, Steven E., Stish, Brad J., Choo, Richard, Lester, Scott, DeWees, Todd A., Vargas, Carlos E.

“…There are limited data regarding using stereotactic body radiation therapy (SBRT) in the postprostatectomy setting. Here, we present a preliminary analysis of…”
Get full text

Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy by Lucido, J. John, Penoncello, Gregory P., Laughlin, Brady S., Armstrong, Michael D., Lo, Stephanie G., Rivera, Judith N., Tang, Xueyan, Chungbin, Suzanne J., Breen, William G., Mangold, Aaron R., Comfere, Nneka I., Lester, Scott C., Rule, William G., Deufel, Christopher L., Foster, Madeline G.

“…Purpose: Subtotal skin electron beam therapy may be an option for patients with cutaneous lymphoma receiving radiation therapy to treat large areas of their…”
Get full text

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study by Laughlin, Brady S., Golafshar, Michael A., Ahmed, Safia, Prince, Matthew, Anderson, Justin D., Vern-Gross, Tamara, Seetharam, Mahesh, Goulding, Krista, Petersen, Ivy, DeWees, Todd, Ashman, Jonathan B.

“…PurposeProton beam therapy (PBT) may provide an advantage when planning well-selected patients with extremity soft tissue sarcoma (eSTS), specifically for…”
Get full text

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer by Anderson, Justin D, Voss, Molly M, Laughlin, Brady S, Garda, Allison E, Aziz, Khaled, Mullikin, Trey C, Haddock, Michael G, Petersen, Ivy A, DeWees, Todd A, Vora, Sujay A

“…To compare Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with endometrial cancer receiving…”
Get full text

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003 by Laughlin, Brady S., Thorpe, Cameron S., DeWees, Todd A., Voss, Molly M., Chang, John H., Hartsell, William F., Sinesi, Christopher C., Rwigema, Jean-Claude M., Keole, Sameer R., Gondi, Vinai, Vargas, Carlos E.

“…Our objective was to report the quality of life (QoL) analysis and toxicity in patients with intermediate-risk prostate cancer treated with or without androgen…”
Get full text

Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience by Laughlin, Brady S., Ebrahimi, Sasha, Voss, Molly M., Patel, Samir H., Foote, Robert L., McGee, Lisa A., Garcia, Joaquin, Ma, Daniel J., Garces, Yolanda I., Wittich, Michelle A. Neben, Price, Katharine A., Schmitt, Alessandra, Zhai, Qihui, May, Byron C., Nagel, Thomas H., Hinni, Michael L., Chintakuntlawar, Ashish V., DeWees, Todd A., Rwigema, Jean-Claude M.

“…This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. Eighty-nine patients…”
Get full text

In Reply to Al-Rashdan by Vargas, Carlos E, Laughlin, Brady S

Get full text

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery by Thorpe, Cameron S., DeWees, Todd A., Laughlin, Brady S., Vallow, Laura A., Seneviratne, Dee, Pockaj, Barbara A., Cronin, Patricia A., Halyard, Michele Y., Vern-Gross, Tamara Z., McGee, Lisa A., McLaughlin, Sarah A., Voss, Molly M., Golafshar, Michael A., Bulman, Gabriella F., Vargas, Carlos E.

“…Our purpose was to report the results of a phase II trial of patients with breast cancer treated with hypofractionated whole breast radiation therapy (RT)…”
Get full text

Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer by Laughlin, Brady S., Anderson, Justin D., Hobbis, Dean, Armstrong, Michael, Vargas, Carlos E., Rong, Yi, Yu, Nathan Y.

Get full text

Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging by Duan, Jingwei, Tegtmeier, Riley C., Vargas, Carlos E., Yu, Nathan Y., Laughlin, Brady S., Rwigema, Jean-Claude M., Anderson, Justin D., Zhu, Libing, Chen, Quan, Rong, Yi

“…•Commercial AI auto-segmentation tools can over-estimate prostate from CT images.•A deep learning AI model is trained using expert contours from CT-MRI…”
Get full text

Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy by Laughlin, Brady S, Zaniletti, Isabella, Foster, Madeline G, Lucido, John, Mangold, Aaron R, Rosenthal, Allison C, VAN DER Walt, Charles, Breen, William, Lester, Scott, Hoppe, Bradford, Petersen, Jennifer, Armstrong, Michael D, Bogan, Aaron, Rule, William G

“…Total skin electron beam therapy (TSEBT) is an effective treatment for managing cutaneous T-cell lymphoma (CTCL), but may result in unnecessary toxicity. With…”
Get more information

Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery by Laughlin, Brady S., Corbin, Kimberly S., Toesca, Diego Augusto Santos, Thorpe, Cameron S., Golafshar, Michael A., Pockaj, Barbara, Cronin, Patricia, McGee, Lisa A., Halyard, Michele Y., Mutter, Robert W., Keole, Sameer R., Park, Sean S., Shumway, Dean A., Vern-Gross, Tamara Z., Vallow, Laura, Wong, William W., DeWees, Todd A., Vargas, Carlos E.

“…Our aim was to report physician- and patient-reported outcomes of patients with localized breast cancer treated with moderate versus ultrahypofractionated…”
Get full text

Long‐term experience with intraoperative electron radiation therapy boost in extremity sarcoma by Laughlin, Brady S., Golafshar, Michael A., Lin, Keldon, Goulding, Krista, Roesler, Kimberly, Vern‐Gross, Tamara, Seetharam, Mahesh, Zaniletti, Isabella, Ashman, Jonathan B.

“…Background In patients with extremity soft tissue sarcoma (eSTS), we describe outcomes of preoperative external beam radiation therapy (EBRT), limb‐sparing…”
Get full text